NFKB1 and inflammatory bowel disease: Baicalin and baicalein have been reported to exhibit antioxidant and anti-inflammatory activities in diabetes, cardiovascular disease, and inflammatory bowel diseases by attenuating the activity of NF-κB and inhibiting the secretion of several inflammatory cytokines [32].